about
Circumferential Fusion through All-Posterior Approach in Andersson Lesion.Osteoblast Role in Rheumatic Diseases.Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.Complement C3 and C5 deficiency affects fracture healingSimultaneous Quantification of Bone Edema/Adiposity and Structure in Inflamed Bone Using Chemical Shift-Encoded MRI in Spondyloarthritis.Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in SwedenSurgical Stabilization Improves Survival of Spinal Fractures Related to Ankylosing SpondylitisUrolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI)C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healingIs allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry studyThe balance of tissue repair and remodeling in chronic arthritis.The role of bone morphogenetic proteins in ankylosing spondylitis.Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis.Bone Disease in Axial Spondyloarthritis.Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study.Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis.Vitamin D levels in patients with ankylosing spondylitis: Is it related to disease activity?
P2860
Q33826594-1B0FA583-2E65-42EC-A881-CE133470412AQ33838967-BE6FE1BE-02B6-42A3-A50F-13199949247AQ34425497-1EA03971-9C2A-4055-A28B-7C81943E85F2Q35049546-0FE695BD-C2BD-4AF2-943E-41B540155F15Q36394657-9C202CE7-E698-48B9-BD10-565096663D6BQ36608425-1D911780-E1F4-4D26-AB0B-686E866FA003Q37052838-104B32D4-EDA8-4ED2-8EBB-A2786E283EB8Q37128528-CEA0D538-45AC-41C2-A587-E9F9C0AD7993Q37369569-3DF0D9D2-82D1-45A9-BF25-66AE9EDF8E0BQ37741922-1F621971-BE6B-4E13-9851-E320C48D2EAFQ37947117-AAAC908A-F631-4CE1-B96A-3CB18B2E0375Q38031830-ACD65B2F-9260-4647-A9E3-E5C72CBBD0C2Q38925780-62755957-902A-497D-88F3-A29FD1F9A896Q41961746-D2B28EC9-A16C-45E7-9686-D2BA81D8335CQ47393253-D4B8F664-4B86-4235-9B82-8DA384BCD55EQ48330300-8C564B26-48BC-41B3-B871-14E56A9CF6FCQ50436452-3FCE8FF1-71C0-4888-A072-F5F1A278A020Q57822981-D5AD0922-5E94-4799-A058-D44BECE1DA2B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteoporosis: a paradox in ankylosing spondylitis.
@en
Osteoporosis: a paradox in ankylosing spondylitis.
@nl
type
label
Osteoporosis: a paradox in ankylosing spondylitis.
@en
Osteoporosis: a paradox in ankylosing spondylitis.
@nl
prefLabel
Osteoporosis: a paradox in ankylosing spondylitis.
@en
Osteoporosis: a paradox in ankylosing spondylitis.
@nl
P2860
P1476
Osteoporosis: a paradox in ankylosing spondylitis
@en
P2093
Shea Carter
P2860
P2888
P304
P356
10.1007/S11914-011-0058-Z
P50
P577
2011-09-01T00:00:00Z